Glaxosmithkline, LLC. Flu vaccine for USP atlanta staff for 2020-2021

Ended Awarded

Contract number
15B30120FVM410001
Awardee
Awarding agency
Obligated
$993

Award facts

Opportunity
Contract value 100% obligated
$992.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27709, USA

Award details come from SAM.gov/FPDS.

About this award

Glaxosmithkline, LLC was awarded a nine hundred ninety-two dollar firm fixed price delivery order against an unspecified contract vehicle to provide flu vaccines for staff at the United States Penitentiary Atlanta, part of the Federal Bureau of Prisons, for the 2020-2021 flu season. The delivery order was awarded on April 20, 2020 with a completion date of September 30, 2020. No set-aside provisions were applied to this award. Glaxosmithkline will deliver the vaccines from its location in Research Triangle Park, North Carolina to support the health of personnel at the Bureau of Prisons facility in Atlanta, Georgia.

Quick answers

Who was awarded contract 15B30120FVM410001?

15B30120FVM410001 was awarded to Glaxosmithkline, LLC by United States Penitentiary Atlanta (Correctional Facilities) on April 20, 2020.

How much is contract 15B30120FVM410001 worth?

The government has obligated $993 on 15B30120FVM410001.

Is contract 15B30120FVM410001 an order under another contract?

Yes. 15B30120FVM410001 is a delivery order under 36E79720D0016, an indefinite delivery contract.

Was contract 15B30120FVM410001 competed?

The extent of competition for 15B30120FVM410001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award